[1]
“Comparison of Panretinal Photocoagulation alone With Panretinal Photocoagulation plus Intravitreal Bevacizumab in Treatment of High Risk Proliferative Diabetic Retinopathy”, J Fatima Jinnah Med Univ, vol. 10, no. 1, Jul. 2018, Accessed: Aug. 07, 2026. Available: https://jfjmu.com/index.php/ojs/article/view/401